Component-Level Trial Findings CJC-1295 (without DAC, modified GRF 1-29) Phase 1 and Phase 2 work described: Dose-dependent GH elevation (2-10x baseline at studied doses, PMID 16352683) IGF-1 elevation of 1.5-3x baseline at 1-2 weeks Mild facial flushing post-injection in some participants No serious adverse events at studied doses CJC-1295 with DAC The DAC-modified version covalently binds to albumin, extending half-life to 5-8 days (PMID 16352683)
Kinjo T, Ham-Terhune J, Peloponese JM Jr, Jeang KT
This overlap suggests a complex interaction between oral and intestinal microecology, where oral bacteria can colonize the gut, significantly influencing various pathophysiological processes
Ingredients like Aloe Vera, Glycerine, and Vitamin E help maintain skin hydration and comfort, making it suitable for daily skincare routines for concerns such as dull skin, uneven skin tone, and acne-prone skin under dermatological guidance
Aqueous solubility of alkylamino-s-triazine as a function of pH and molecular structure